BIT

5.88%

1.8¢

BIOTRON LIMITED

Market Cap $16.24M Add to my watchlist

Healthcare Biotechnology

Biotron Limited is an Australia-based biotechnology company. The Company is primarily... Biotron Limited is an Australia-based biotechnology company. The Company is primarily engaged in the funding and management of intermediate and applied biotechnology research and development projects. The Company’s clinical programs include BIT225-001, BIT225-003, BIT225-004, BIT225-005, BIT225-006, BIT225-007 and BIT225-008. BIT225 is in mid-stage clinical development for treatment of HIV-1 and Hepatitis C virus (HCV) infections, with seven clinical trials completed. BIT225 is a HIV-1 Vpu protein inhibitor with the aim of inhibiting virus replication in cellular reservoirs. BIT225 is a viral assembly inhibitor that targets HCV p7 protein. In addition to the development of BIT225, the Company has a portfolio of preclinical antiviral programs developing drugs targeting a range of significant established and emerging viral diseases such as Dengue, Zika and Influenza virus.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Latest Threads

Tag

Subject

BIT

Ann: Agreement with C14 Consulting Group

2 3 4

12:22

191

46K

12:22

Last post luxury

191

46K

BIT

Biotron's Commercial Partner

26/12/24

407

26/12/24

Last post a2zz

407

BIT

Breathtaking Incompetence

2 3 4

25/12/24

236

55K

25/12/24

Last post Footmax

236

55K

BIT

Ann: Final Director's Interest Notice S.P. $ S.L.

06/12/24

1.1K

06/12/24

Last post Bullrush007

1.1K

BIT

Ann: Results of Meeting AGM

02/12/24

19K

02/12/24

Last post Footmax

19K

BIT

Ann: Presentation to Annual General Meeting

15:26

11K

15:26

Last post Footmax

11K

BIT

Ann: Change of Director's Interest Notice M.M, M.H, R.T.

28/11/24

553

28/11/24

Last post

ASX News

553

BIT

Ann: Application for quotation of securities - BIT

26/11/24

5.2K

26/11/24

Last post Pseudoname1

5.2K

See All Discussions

Timeline

Change of Director's Interest Notice M.M, M.H, R.T.
28 Nov 16:04	Share

Final Director's Interest Notice S.P. $ S.L.
28 Nov 15:57	Share

Results of Meeting AGM
28 Nov 15:50	Share

Presentation to Annual General Meeting
28 Nov 10:13	Share

Agreement with C14 Consulting Group
27 Nov 09:47	Share

Application for quotation of securities - BIT
25 Nov 13:58	Share

Application for quotation of securities - BIT
19 Nov 15:16	Share

Revised Continuous Disclosure Policy
15 Nov 10:01	Share

Application for quotation of securities - BIT
12 Nov 15:35	Share

Cancel - Application for quotation of securities - BIT
12 Nov 15:26	Share

Application for quotation of securities - BIT
12 Nov 13:03	Share

Quarterly Activities/Appendix 4C Cash Flow Report
30 Oct 08:56	Share

Typographical error
25 Oct 14:51	Share

Option Expiry Notice
24 Oct 09:04	Share

Annual Report/Notice of AGM/Proxy Form
22 Oct 10:51	Share

$1.8M R&D Rebate Received
14 Oct 09:52	Share

Response to ASX Aware Query
25 Sep 10:38	Share

BIT225-012 PHASE 2 COVID-19 CLINICAL TRIAL
06 Sep 09:37	Share

Appendix 4G
30 Aug 08:06	Share

Corporate Governance Statement
30 Aug 08:06	Share

Full Year Statutory Accounts and Appendix 4E
30 Aug 08:05	Share

Application for quotation of securities - BIT
15 Aug 11:05	Share

Quarterly Activities/Appendix 4C Cash Flow Report
31 Jul 08:52	Share

Application for quotation of securities - BIT
22 Jul 14:19	Share

Letter to Shareholders
11 Jul 10:35	Share

Webinar Investors Presentation
26 Jun 13:06	Share

BIOTRON CLINICAL TRIAL RESULTS WEBINAR
25 Jun 13:21	Share

BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives
19 Jun 09:47	Share

Change of Share Registry address
23 May 09:41	Share

Quarterly Activities/Appendix 4C Cash Flow Report
26 Apr 08:30	Share

View More

(20min delay)
Last 1.8¢		Change 0.001(5.88%)		Mkt cap ! $16.24M

Open	High	Low	Value	Volume
1.6¢	1.8¢	1.6¢	$9.322K	556.2K

Buyers (Bids)

No.	Vol.	Price($)
10	1830937	1.6¢

Sellers (Offers)

Price($)	Vol.	No.
1.8¢	293053	5

View Market Depth

No.	Vol.	Price($)
10	1830937	0.016
6	835662	0.015
2	450100	0.014
1	158888	0.013
4	1263330	0.012

Price($)	Vol.	No.
0.018	293053	5
0.019	550913	2
0.020	548442	3
0.021	211762	3
0.022	2570862	7

Last trade - 16.10pm 27/12/2024 (20 minute delay)

BIT (ASX) Chart

BIOTRON LIMITED

Corporate Spotlight
Not Yet Available

Latest Threads

Timeline

Featured News

Latest Articles

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

Biotron (ASX:BIT) has angered shareholders on HotCopper on Friday as the results of its latest COVID-facing trial come up dusty.

Biotron jumps over 14% on latest HIV Phase 2 results; liquidity notably boosted

Shares in otherwise thinly traded healthcare microcap Biotron Limited (ASX:BIT) jumped 14.6% on Wednesday following trial results.

Biotron (ASX:BIT) kicks off phase II COVID-19 clinical trial in Thailand

Biotron (ASX:BIT) has kicked off a phase II trial of its lead antiviral drug, BIT225, to treat COVID-19 within three days of the onset of symptoms over seven days of treatment.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News

BIOTRON LIMITED

Corporate SpotlightNot Yet Available

Latest Threads

Timeline

Featured News

Latest Articles

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

Biotron (ASX:BIT) has angered shareholders on HotCopper on Friday as the results of its latest COVID-facing trial come up dusty.

Biotron jumps over 14% on latest HIV Phase 2 results; liquidity notably boosted

Shares in otherwise thinly traded healthcare microcap Biotron Limited (ASX:BIT) jumped 14.6% on Wednesday following trial results.

Biotron (ASX:BIT) kicks off phase II COVID-19 clinical trial in Thailand

Biotron (ASX:BIT) has kicked off a phase II trial of its lead antiviral drug, BIT225, to treat COVID-19 within three days of the onset of symptoms over seven days of treatment.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News

Corporate Spotlight
Not Yet Available